Research progress of perioperative treatment for esophagogastric junction adenocarcinoma
The incidence of esophagogastric junction adenocarcinoma is still high in China.In recent years,surgical treatment combined with chemotherapy,radiotherapy,immunotherapy,and targeted therapy has gradually improved the prognosis of patients with gastric cancer,but there are still many controversies in the perioperative treatment.This study summarized the research progress related to perioperative treatment for esophagogastric junction adenocarcinoma,including preoperative neoadjuvant therapy,postoperative adjuvant therapy,perioperative radiotherapy,and immunotherapy,so as to clarify the current research direction.
万方数据
维普
